{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:24:02Z","timestamp":1763018642767,"version":"3.40.5"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071631744"},{"type":"electronic","value":"9781071631751"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3175-1_11","type":"book-chapter","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:02:13Z","timestamp":1684479733000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Laboratory Testing for Activated Protein C Resistance (APCR): An Update"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny","family":"Vong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-6743","authenticated-orcid":false,"given":"Leonardo","family":"Pasalic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","volume":"90","author":"B Dahlback","year":"1993","unstructured":"Dahlback B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci 90:1004\u20131008","journal-title":"Proc Natl Acad Sci"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1055\/s-0029-1242722","volume":"35","author":"A Coppola","year":"2009","unstructured":"Coppola A, Tufano A, Cerbone AM, Di Minno G (2009) Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost 35:683\u2013694","journal-title":"Semin Thromb Hemost"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1055\/s-0034-1544003","volume":"41","author":"G Lippi","year":"2015","unstructured":"Lippi G, Danese E, Favaloro EJ, Montagnana M, Franchini M (2015) Diagnostics in venous thromboembolism: from origin to future prospects. Semin Thromb Hemost 41:374\u2013381","journal-title":"Semin Thromb Hemost"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/369064a0","volume":"69","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BPC, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 69:64\u201367","journal-title":"Nature"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(94)92939-4","volume":"343","author":"J Voorberg","year":"1994","unstructured":"Voorberg J, Roelse J, Koopman R et al (1994) Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet 343:1535\u20131536","journal-title":"Lancet"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0140-6736(94)92940-8","volume":"343","author":"B Zoller","year":"1994","unstructured":"Zoller B, Dahlback B (1994) Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343:1536\u20131538","journal-title":"Lancet"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1172\/JCI117623","volume":"94","author":"B Zoller","year":"1994","unstructured":"Zoller B, Svensson PJ, He X, Dahlback B (1994) Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 94:2521\u20132524","journal-title":"J Clin Invest"},{"key":"11_CR8","doi-asserted-by":"publisher","unstructured":"Paji\u010d T (2023) Testing for Factor V Leiden (FVL) and prothrombin G20210A genetic variants. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 233\u2013251. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_14","DOI":"10.1007\/978-1-0716-3175-1_14"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4939-7196-1_10","volume":"1646","author":"S Mohammed","year":"2017","unstructured":"Mohammed S, Favaloro EJ (2017) Laboratory testing for activated protein C resistance (APCR). Methods Mol Biol 1646:137\u2013143. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_10","journal-title":"Methods Mol Biol"},{"key":"11_CR10","first-page":"23","volume":"56","author":"EJ Favaloro","year":"1999","unstructured":"Favaloro EJ, Mirochnik O, McDonald D (1999) Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT- than APTT- based assays. Br J Biomed Sci 56:23\u201333","journal-title":"Br J Biomed Sci"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/003130202760120526","volume":"34","author":"EJ Favaloro","year":"2002","unstructured":"Favaloro EJ, Orsag I, Bukuya M, McDonald D (2002) A nine-year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations. Pathology 34:348\u2013355","journal-title":"Pathology"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1309\/QCUUNRMVJY8MWPPL","volume":"119","author":"LL Graf","year":"2003","unstructured":"Graf LL, Welsh CH, Qamar Z, Marlar RA (2003) Activated protein C resistance assay detects thrombotic risk factors other than Factor V Leiden. Am J Clin Pathol 119:52\u201360","journal-title":"Am J Clin Pathol"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/PAT.0b013e328344e5fc","volume":"43","author":"EJ Favaloro","year":"2011","unstructured":"Favaloro EJ, Mohammed S, Pati N, Manyuk H, McDonald D (2011) A clinical audit of congenital thrombophilia investigation in tertiary practice. Pathology 43:266\u2013272","journal-title":"Pathology"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2141.2006.06138.x","volume":"134","author":"EJ Favaloro","year":"2006","unstructured":"Favaloro EJ (2006) More on \u2018universal\u2019 versus \u2018selected\u2019 screening for thrombophilia: the hidden costs of false-positive diagnosis. Br J Haematol 134:239\u2013240","journal-title":"Br J Haematol"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1055\/s-0029-1242723","volume":"35","author":"EJ Favaloro","year":"2009","unstructured":"Favaloro EJ, McDonald D, Lippi G (2009) Laboratory evaluation of thrombophilia: the good, the bad and the ugly. Semin Thromb Hemost 35:695\u2013710","journal-title":"Semin Thromb Hemost"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/cclm-2013-0560","volume":"52","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro EJ (2014) The futility of thrombophilia testing. Clin Chem Lab Med 52:499\u2013503","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"11_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2450\/2016.0301-16","volume":"15","author":"EJ Favaloro","year":"2017","unstructured":"Favaloro EJ, Lippi G (2017) Interference of direct oral anticoagulants (DOACs) in hemostasis assays: high potential for diagnostic false positives and false negatives. Blood Transfus 15(6):491\u2013494. https:\/\/doi.org\/10.2450\/2016.0301-16","journal-title":"Blood Transfus"},{"issue":"3","key":"11_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-0038-1627480","volume":"118","author":"RC Gosselin","year":"2018","unstructured":"Gosselin RC, Adcock DM, Bates SM et al (2018) International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost 118(3):437\u2013450. https:\/\/doi.org\/10.1055\/s-0038-1627480","journal-title":"Thromb Haemost"},{"issue":"8","key":"11_CR19","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1055\/a-1450-8178","volume":"121","author":"J Douxfils","year":"2021","unstructured":"Douxfils J, Adcock D, Bates SM et al (2021) 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost 121(8):1008\u20131020. https:\/\/doi.org\/10.1055\/a-1450-8178","journal-title":"Thromb Haemost"},{"issue":"8","key":"11_CR20","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1515\/cclm-2019-1160","volume":"58","author":"EJ Favaloro","year":"2020","unstructured":"Favaloro EJ, Gilmore G, Bonar R, Dean E, Arunachalam S, Mohammed S, Baker R (2020) Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference. Clin Chem Lab Med 58(8):1322\u20131331. https:\/\/doi.org\/10.1515\/cclm-2019-1160","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl 1","key":"11_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ijlh.13196","volume":"42","author":"T Exner","year":"2020","unstructured":"Exner T, Rigano J, Favaloro EJ (2020) The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays. Int J Lab Hematol 42(Suppl 1):41\u201348. https:\/\/doi.org\/10.1111\/ijlh.13196","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"11_CR22","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1515\/cclm-2021-0499","volume":"59","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Mohammed S, Vong R et al (2021) A multi-laboratory assessment of congenital thrombophilia assays performed on the ACL Top 50 family for harmonisation of thrombophilia testing in a large laboratory network. Clin Chem Lab Med 59(10):1709\u20131718. https:\/\/doi.org\/10.1515\/cclm-2021-0499","journal-title":"Clin Chem Lab Med"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.thromres.2005.06.011","volume":"117","author":"EJ Favaloro","year":"2006","unstructured":"Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L (2006) Activated protein C resistance: the influence of ABO-blood group, gender and age. Thromb Res 117:665\u2013670","journal-title":"Thromb Res"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/aob.2020.02.06","volume":"5","author":"E Dean","year":"2020","unstructured":"Dean E, Favaloro EJ (2020) The changing face of activated protein C resistance testing \u2013 a 10-year retrospective. Ann Blood 5:6. https:\/\/doi.org\/10.21037\/aob.2020.02.06","journal-title":"Ann Blood"},{"key":"11_CR25","doi-asserted-by":"publisher","unstructured":"Favaloro EJ, Mohammed S, Vong R, Leonardo Pasalic P (2023) Harmonization of hemostasis testing across a large laboratory network: an example from Australia. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 71\u201391. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_5","DOI":"10.1007\/978-1-0716-3175-1_5"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3175-1_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:05:15Z","timestamp":1684479915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3175-1_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631744","9781071631751"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_11","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"20 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}